Ann Merrifield

Who is Ann Merrifield?

Ann Merrifield joined Genzyme in 1992. She is responsible for managing

all aspects of the orthopaedics and biosurgical specialties business

units of Genzyme Biosurgery, including Synvisc and all other

biomaterials products. Ms. Merrifield has also served as president of

Genzyme Genetics. Prior to joining Genzyme, she was a partner at Bain

and Company and an investment analyst for Aetna Life and Casualty. Ms.

Merrifield has an M.B.A. from the Tuck School at Dartmouth College and

a B.A. and M.Ed. from the University of Maine.